Epithelial ovarian cancer is a medical condition with active clinical research programs worldwide.

15 total trials for this combination

Showing top 10 of 15 trials

Trials

NCT ID	Title	Status	Phase
NCT04925284	Study of XB002 in Subjects With Solid Tumors (JEWEL-101)	COMPLETED	PHASE1
NCT03106987	A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer.	COMPLETED	PHASE3
NCT01891344	A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)	COMPLETED	PHASE2
NCT04296890	A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression	COMPLETED	PHASE3
NCT02631876	A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer	COMPLETED	PHASE3
NCT03522246	A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy	ACTIVE_NOT_RECRUITING	PHASE3
NCT02855944	ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients	COMPLETED	PHASE3
NCT05620134	Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer	ACTIVE_NOT_RECRUITING	PHASE1/PHASE2
NCT05483933	Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers	COMPLETED	PHASE1
NCT04802876	Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors	ACTIVE_NOT_RECRUITING	PHASE2

Related Pages

All Epithelial ovarian cancer trials All trials in Barcelona, Spain